agilon health Inc (AGL)
Cours de l'action
Loading...
•
Achat
•
Vente
•
Achat planifié
•
Vente planifiée
Achat net
Vente nette
Résultats financiers
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2024-12-13 | 2024-12-13 | A Achat | Administrateur non-exécutif |
25 000
+51.9%
2,2055 085 USD |
25 000 +51.9% | 2,20 | 55 085 USD | |
| 2024-12-13 | 2024-12-11 | A Achat | Administrateur non-exécutif |
25 062
+61.0%
2,0150 269 USD |
25 062 +61.0% | 2,01 | 50 269 USD | |
| 2024-12-11 | 2024-12-09 | A Achat | Administrateur non-exécutif |
7 500
+14.6%
2,2016 489 USD |
7 500 +14.6% | 2,20 | 16 489 USD | |
| 2024-12-11 | 2024-12-05 | A Achat | Administrateur non-exécutif |
45 000
+27.9%
2,1898 145 USD |
45 000 +27.9% | 2,18 | 98 145 USD | |
| 2024-12-11 | 2024-11-25 | A Achat | Administrateur non-exécutif |
12 500
+32.2%
2,2828 474 USD |
12 500 +32.2% | 2,28 | 28 474 USD | |
| 2024-09-16 | 2024-09-12 | A Achat |
CEO & President Administrateur exécutif |
20 000
+42.0%
3,3667 188 USD |
20 000 +42.0% | 3,36 | 67 188 USD | |
| 2024-03-18 | 2024-03-14 | A Achat |
Chief Technology Officer Dirigeant |
5 434
0,000 USD |
5 434 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | A Achat |
Chief Financial Officer Dirigeant |
14 945
0,000 USD |
14 945 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | A Achat |
Chief Markets Officer Dirigeant |
274 455
0,000 USD |
274 455 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | A Achat |
Chief Med. & Quality Officer Dirigeant |
5 434
0,000 USD |
5 434 | 0,00 | 0 USD | |
| 2024-03-18 | 2024-03-14 | A Achat |
Chief Strategy & Dev. Officer Dirigeant |
11 956
0,000 USD |
11 956 | 0,00 | 0 USD | |
| 2023-11-30 | 2023-11-29 | A Achat | Administrateur non-exécutif |
22 300
+231.5%
11,22250 206 USD |
22 300 +231.5% | 11,22 | 250 206 USD | |
| 2023-11-21 | 2023-11-21 | A Achat |
CEO & President Administrateur exécutif |
44 690
+1541.0%
11,14497 739 USD |
44 690 +1541.0% | 11,14 | 497 739 USD | |
| 2023-09-14 | 2023-09-13 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-19.1%
18,00337 455 USD |
18 750 -19.1% | 18,00 | 337 455 USD | |
| 2023-09-14 | 2023-09-12 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-19.1%
18,05338 481 USD |
18 750 -19.1% | 18,05 | 338 481 USD | |
| 2023-09-13 | 2023-09-11 | V Vente |
Chief Accounting Officer Dirigeant |
8 750
-33.8%
18,61162 838 USD |
8 750 -33.8% | 18,61 | 162 838 USD | |
| 2023-09-13 | 2023-09-11 | V Vente |
Chief Accounting Officer Dirigeant |
17 500
-50.5%
18,62325 778 USD |
17 500 -50.5% | 18,62 | 325 778 USD | |
| 2023-08-16 | 2023-08-15 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-19.1%
18,10339 309 USD |
18 750 -19.1% | 18,10 | 339 309 USD | |
| 2023-08-16 | 2023-08-14 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-19.1%
18,72351 083 USD |
18 750 -19.1% | 18,72 | 351 083 USD | |
| 2023-07-14 | 2023-07-13 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-19.1%
16,93317 424 USD |
18 750 -19.1% | 16,93 | 317 424 USD | |
| 2023-07-14 | 2023-07-12 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-19.1%
16,97318 182 USD |
18 750 -19.1% | 16,97 | 318 182 USD | |
| 2023-06-16 | 2023-06-15 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-19.1%
18,73351 103 USD |
18 750 -19.1% | 18,73 | 351 103 USD | |
| 2023-06-16 | 2023-06-14 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
1 100
-1.4%
19,1721 084 USD |
1 100 -1.4% | 19,17 | 21 084 USD | |
| 2023-06-16 | 2023-06-14 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
15 799
-16.6%
18,60293 868 USD |
15 799 -16.6% | 18,60 | 293 868 USD | |
| 2023-06-16 | 2023-06-14 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
1 851
-2.3%
17,9333 194 USD |
1 851 -2.3% | 17,93 | 33 194 USD | |
| 2023-05-18 | 2023-05-18 | V Vente |
CD&R Investment Associates IX, Ltd. Actionnaire important |
94 173 804
-48.5%
20,801 958 937 549 USD |
94 173 804 -48.5% | 20,80 | 1 958 937 549 USD | |
| 2023-05-17 | 2023-05-16 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
25 000
-23.9%
23,14578 535 USD |
25 000 -23.9% | 23,14 | 578 535 USD | |
| 2023-05-17 | 2023-05-15 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
25 000
-23.9%
23,79594 733 USD |
25 000 -23.9% | 23,79 | 594 733 USD | |
| 2023-05-11 | 2023-05-09 | VP Vente planifiée |
Chief Strategy & Dev. Officer Dirigeant |
4 500
-1.5%
26,15117 666 USD |
4 500 -1.5% | 26,15 | 117 666 USD | |
| 2023-04-21 | 2023-04-20 | VP Vente planifiée |
Chief Strategy & Dev. Officer Dirigeant |
500
-0.2%
26,1513 074 USD |
500 -0.2% | 26,15 | 13 074 USD | |
| 2023-04-21 | 2023-04-19 | VP Vente planifiée |
Chief Strategy & Dev. Officer Dirigeant |
455
-0.2%
27,8412 666 USD |
455 -0.2% | 27,84 | 12 666 USD | |
| 2023-04-21 | 2023-04-19 | VP Vente planifiée |
Chief Strategy & Dev. Officer Dirigeant |
4 545
-1.5%
26,82121 877 USD |
4 545 -1.5% | 26,82 | 121 877 USD | |
| 2023-04-19 | 2023-04-18 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
25 000
-23.9%
28,05701 130 USD |
25 000 -23.9% | 28,05 | 701 130 USD | |
| 2023-04-19 | 2023-04-17 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
1 400
-1.7%
28,5439 957 USD |
1 400 -1.7% | 28,54 | 39 957 USD | |
| 2023-04-19 | 2023-04-17 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
23 600
-22.6%
27,70653 640 USD |
23 600 -22.6% | 27,70 | 653 640 USD | |
| 2023-03-27 | 2023-03-24 | VP Vente planifiée |
Chief Strategy & Dev. Officer Dirigeant |
97 290
-26.0%
28,702 792 379 USD |
97 290 -26.0% | 28,70 | 2 792 379 USD | |
| 2023-03-27 | 2023-03-23 | VP Vente planifiée |
Chief Strategy & Dev. Officer Dirigeant |
22 710
-7.6%
28,71651 911 USD |
22 710 -7.6% | 28,71 | 651 911 USD | |
| 2023-03-24 | 2023-03-23 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
8 094
-12.7%
28,04226 978 USD |
8 094 -12.7% | 28,04 | 226 978 USD | |
| 2023-03-24 | 2023-03-22 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
8 094
-12.7%
27,84225 376 USD |
8 094 -12.7% | 27,84 | 225 376 USD | |
| 2023-03-17 | 2023-03-16 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
10 581
-14.9%
26,08275 965 USD |
10 581 -14.9% | 26,08 | 275 965 USD | |
| 2023-03-17 | 2023-03-16 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
9 831
-12.1%
25,65252 192 USD |
9 831 -12.1% | 25,65 | 252 192 USD | |
| 2023-03-17 | 2023-03-16 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
4 588
-5.4%
24,36111 741 USD |
4 588 -5.4% | 24,36 | 111 741 USD | |
| 2023-03-17 | 2023-03-16 | VP Vente planifiée |
Chief Strategy & Dev. Officer Dirigeant |
60 000
-17.8%
26,091 565 196 USD |
60 000 -17.8% | 26,09 | 1 565 196 USD | |
| 2023-03-17 | 2023-03-15 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
25 000
-29.2%
23,80595 075 USD |
25 000 -29.2% | 23,80 | 595 075 USD | |
| 2023-03-17 | 2023-03-15 | V Vente |
Chief Markets Officer Dirigeant |
35 000
-29.0%
23,81833 231 USD |
35 000 -29.0% | 23,81 | 833 231 USD | |
| 2023-03-17 | 2023-03-15 | V Vente | Administrateur non-exécutif |
80 000
-39.3%
23,821 905 224 USD |
80 000 -39.3% | 23,82 | 1 905 224 USD | |
| 2023-03-17 | 2023-03-15 | V Vente |
Chief Med. & Quality Officer Dirigeant |
55 000
-49.8%
23,811 309 424 USD |
55 000 -49.8% | 23,81 | 1 309 424 USD | |
| 2023-03-09 | 2023-03-08 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
8 094
-43.7%
24,44197 821 USD |
8 094 -43.7% | 24,44 | 197 821 USD | |
| 2023-03-09 | 2023-03-07 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
8 094
-43.7%
24,36197 197 USD |
8 094 -43.7% | 24,36 | 197 197 USD | |
| 2023-02-16 | 2023-02-15 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
28 555
-52.7%
23,37667 342 USD |
28 555 -52.7% | 23,37 | 667 342 USD | |
| 2023-02-16 | 2023-02-15 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
8 094
-43.7%
22,98186 028 USD |
8 094 -43.7% | 22,98 | 186 028 USD | |
| 2023-02-16 | 2023-02-14 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
50 000
-66.1%
22,981 149 060 USD |
50 000 -66.1% | 22,98 | 1 149 060 USD | |
| 2023-02-16 | 2023-02-14 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
25 881
-71.3%
22,99594 877 USD |
25 881 -71.3% | 22,99 | 594 877 USD | |
| 2023-02-03 | 2023-02-02 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
30 782
-74.7%
22,99707 561 USD |
30 782 -74.7% | 22,99 | 707 561 USD | |
| 2023-02-03 | 2023-02-01 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 396
-34.1%
21,76117 420 USD |
5 396 -34.1% | 21,76 | 117 420 USD | |
| 2023-01-23 | 2023-01-20 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 396
-34.1%
19,92107 496 USD |
5 396 -34.1% | 19,92 | 107 496 USD | |
| 2023-01-23 | 2023-01-19 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
10 792
-50.9%
19,73212 943 USD |
10 792 -50.9% | 19,73 | 212 943 USD | |
| 2023-01-19 | 2023-01-18 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
20 723
-44.7%
19,78409 889 USD |
20 723 -44.7% | 19,78 | 409 889 USD | |
| 2023-01-19 | 2023-01-17 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
25 722
-50.1%
19,91512 225 USD |
25 722 -50.1% | 19,91 | 512 225 USD | |
| 2023-01-09 | 2023-01-06 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
2 698
-20.6%
15,4641 702 USD |
2 698 -20.6% | 15,46 | 41 702 USD | |
| 2023-01-09 | 2023-01-05 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
2 698
-20.6%
15,5141 845 USD |
2 698 -20.6% | 15,51 | 41 845 USD | |
| 2022-12-19 | 2022-12-16 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 398
-34.1%
16,8290 807 USD |
5 398 -34.1% | 16,82 | 90 807 USD | |
| 2022-12-19 | 2022-12-15 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 398
-34.1%
17,4294 013 USD |
5 398 -34.1% | 17,42 | 94 013 USD | |
| 2022-12-16 | 2022-12-15 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-42.3%
17,26323 663 USD |
18 750 -42.3% | 17,26 | 323 663 USD | |
| 2022-12-16 | 2022-12-14 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-42.3%
17,52328 491 USD |
18 750 -42.3% | 17,52 | 328 491 USD | |
| 2022-12-07 | 2022-12-06 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 398
-34.1%
17,7295 632 USD |
5 398 -34.1% | 17,72 | 95 632 USD | |
| 2022-12-07 | 2022-12-05 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 398
-34.1%
17,8096 079 USD |
5 398 -34.1% | 17,80 | 96 079 USD | |
| 2022-11-22 | 2022-11-18 | A Achat |
CEO & President Administrateur exécutif |
2 900
+inf%
17,1449 705 USD |
2 900 +inf% | 17,14 | 49 705 USD | |
| 2022-11-18 | 2022-11-17 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 396
-34.1%
17,4394 055 USD |
5 396 -34.1% | 17,43 | 94 055 USD | |
| 2022-11-18 | 2022-11-17 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-42.3%
17,17321 956 USD |
18 750 -42.3% | 17,17 | 321 956 USD | |
| 2022-11-18 | 2022-11-16 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 396
-34.1%
18,5299 919 USD |
5 396 -34.1% | 18,52 | 99 919 USD | |
| 2022-11-18 | 2022-11-16 | VP Vente planifiée |
Chief Markets Officer Dirigeant |
18 750
-42.3%
18,29343 009 USD |
18 750 -42.3% | 18,29 | 343 009 USD | |
| 2022-11-03 | 2022-11-02 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 396
-34.1%
19,53105 407 USD |
5 396 -34.1% | 19,53 | 105 407 USD | |
| 2022-11-03 | 2022-11-01 | VP Vente planifiée |
Chief Med. & Quality Officer Dirigeant |
5 396
-34.1%
20,03108 093 USD |
5 396 -34.1% | 20,03 | 108 093 USD | |
| 2022-10-21 | 2022-10-20 | V Vente |
Chief Markets Officer Dirigeant |
1 500
-5.5%
20,6630 991 USD |
1 500 -5.5% | 20,66 | 30 991 USD |